- Home
- CRNX vs CWAN Comparison
CRNX vs CWAN Comparison
Compare CRNX & CWAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRNX
- CWAN
- Stock Information
- Founded
- CRNX 2008
- CWAN 2004
- Country
- CRNX United States
- CWAN United States
- Employees
- CRNX N/A
- CWAN N/A
- Industry
- CRNX Biotechnology: Pharmaceutical Preparations
- CWAN Computer Software: Prepackaged Software
- Sector
- CRNX Health Care
- CWAN Technology
- Exchange
- CRNX Nasdaq
- CWAN Nasdaq
- Market Cap
- CRNX 5.2B
- CWAN 5.5B
- IPO Year
- CRNX 2018
- CWAN 2021
- Fundamental
- Price
- CRNX $37.46
- CWAN $31.27
- Analyst Decision
- CRNX Strong Buy
- CWAN Buy
- Analyst Count
- CRNX 12
- CWAN 9
- Target Price
- CRNX $72.64
- CWAN $34.44
- AVG Volume (30 Days)
- CRNX 747.4K
- CWAN 2.4M
- Earning Date
- CRNX 02-27-2025
- CWAN 02-19-2025
- Dividend Yield
- CRNX N/A
- CWAN N/A
- EPS Growth
- CRNX N/A
- CWAN N/A
- EPS
- CRNX N/A
- CWAN 1.68
- Revenue
- CRNX $1,038,999.00
- CWAN $451,803,000.00
- Revenue This Year
- CRNX N/A
- CWAN $23.48
- Revenue Next Year
- CRNX $206.01
- CWAN $19.67
- P/E Ratio
- CRNX N/A
- CWAN $18.61
- Revenue Growth
- CRNX N/A
- CWAN 22.72
- 52 Week Low
- CRNX $34.07
- CWAN $15.62
- 52 Week High
- CRNX $62.53
- CWAN $35.71
- Technical
- Relative Strength Index (RSI)
- CRNX 42.29
- CWAN 66.65
- Support Level
- CRNX $35.10
- CWAN $26.71
- Resistance Level
- CRNX $35.85
- CWAN $32.00
- Average True Range (ATR)
- CRNX 1.45
- CWAN 0.95
- MACD
- CRNX 0.47
- CWAN 0.24
- Stochastic Oscillator
- CRNX 49.78
- CWAN 86.26
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.
About CWAN Clearwater Analytics Holdings Inc.
Clearwater Analytics Holdings Inc provides a SaaS solution for automated investment data aggregation, reconciliation, accounting and reporting services to insurers, investment managers, corporations, institutional investors and government entities. It earns revenue from providing access to its SaaS platform to customers, services that support the implementation on the SaaS platform, selling perpetual and term-based software licenses and providing maintenance and support and professional services under contracts with customers. The majority of the revenue is earned in the United States.